Butterfly Network (BFLY)
(Delayed Data from NYSE)
$1.72 USD
+0.04 (2.38%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $1.71 -0.01 (-0.58%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.72 USD
+0.04 (2.38%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $1.71 -0.01 (-0.58%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth B Momentum C VGM
Zacks News
GEHC's MIM Software to Aid Radiation Therapy With Its Latest FDA Nod
by Zacks Equity Research
GE Healthcare's MIM Software announces the FDA clearance of Monte Carlo Dosimetry for Theranostics, enhancing precision in personalized treatment plans.
Is Achilles Therapeutics (ACHL) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how Achilles Therapeutics PLC Sponsored ADR (ACHL) and Butterfly Network, Inc. (BFLY) have performed compared to their sector so far this year.
Is Butterfly Network (BFLY) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Butterfly Network, Inc. (BFLY) and Brainsway Ltd. Sponsored ADR (BWAY) have performed compared to their sector so far this year.
Butterfly Network's Stock Surges on iQ3 Device Launch in Europe
by Zacks Equity Research
Shares of BFLY gain almost 27% following the announcement of the launch of its latest handheld ultrasound device, Butterfly iQ3, in Europe.
Butterfly Network, Inc. (BFLY) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Butterfly Network (BFLY) delivered earnings and revenue surprises of 50% and 7.11%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
ImmunoPrecise Antibodies Ltd. (IPA) Reports Q4 Loss, Lags Revenue Estimates
by Zacks Equity Research
ImmunoPrecise Antibodies (IPA) delivered earnings and revenue surprises of -420% and 3.29%, respectively, for the quarter ended April 2024. Do the numbers hold clues to what lies ahead for the stock?
Butterfly Network (BFLY) Unveils iQ+ Bladder Ultrasound Scanner
by Zacks Equity Research
Butterfly Network (BFLY) uses proprietary Ultrasound-on-Chip technology to streamline the bladder scanning process.
5 Medical Info Systems Stocks to Buy for Stable Returns
by Nalak Das
We have narrowed our search to five medical info systems stocks that have strong growth potential for 2024. These stocks are: HIMS, BFLY, ENOV, LUNG, DH.
Are Medical Stocks Lagging Butterfly Network (BFLY) This Year?
by Zacks Equity Research
Here is how Butterfly Network, Inc. (BFLY) and BellRing Brands (BRBR) have performed compared to their sector so far this year.
Butterfly Network, Inc. (BFLY) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Butterfly Network, Inc. (BFLY) delivered earnings and revenue surprises of -75% and 3.35%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Enovis (ENOV) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
by Zacks Equity Research
Enovis (ENOV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Butterfly Network, Inc. (BFLY) Upgraded to Buy: Here's Why
by Zacks Equity Research
Butterfly Network, Inc. (BFLY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Butterfly Network, Inc. (BFLY) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Butterfly Network, Inc. (BFLY) delivered earnings and revenue surprises of 17.65% and 6.46%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Axonics Modulation Technologies (AXNX) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Axonics (AXNX) delivered earnings and revenue surprises of -25% and 7.67%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Butterfly Network, Inc. (BFLY) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Butterfly Network, Inc. (BFLY) delivered earnings and revenue surprises of 15% and 1.86%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Sonendo, Inc. (SONX) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Sonendo, Inc. (SONX) delivered earnings and revenue surprises of -6.67% and 0.13%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Why Butterfly Network (BFLY) Might Surprise This Earnings Season
by Zacks Equity Research
Butterfly Network (BFLY) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
IRhythm Technologies (IRTC) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
iRhythm Technologies (IRTC) delivered earnings and revenue surprises of -61.25% and 3.60%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Butterfly Network, Inc. (BFLY) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Butterfly Network, Inc. (BFLY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is Butterfly Network (BFLY) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how Butterfly Network, Inc. (BFLY) and Haemonetics (HAE) have performed compared to their sector so far this year.
iRhythm Technologies (IRTC) Soars 3.9%: Is Further Upside Left in the Stock?
by Zacks Equity Research
iRhythm Technologies (IRTC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Butterfly Network, Inc. (BFLY) Reports Q4 Loss, Lags Revenue Estimates
by Zacks Equity Research
Butterfly Network, Inc. (BFLY) delivered earnings and revenue surprises of 19.05% and 5.58%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Is Butterfly Network (BFLY) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Butterfly Network, Inc. (BFLY) and Biora Therapeutics, Inc. (BIOR) have performed compared to their sector so far this year.
Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for XHE
Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?
by Zacks Equity Research
Sector ETF report for XHE